Department of Rheumatology, Middlemore Hospital, Auckland, New Zealand.
Department of Respiratory, Middlemore Hospital, Auckland, New Zealand.
Intern Med J. 2020 Apr;50(4):484-487. doi: 10.1111/imj.14789.
Anti-MDA5-associated dermatomyositis (MDA5-associated DM) is an uncommon presentation of idiopathic inflammatory myositis, typically amyopathic, associated with rapidly progressive, treatment refractory interstitial lung disease and poor prognosis, particularly in patients with concomitant rapidly progressive interstitial lung disease (RP-ILD). We report two cases of MDA5-associated DM with fatal outcome in one of the patients, despite 'aggressive triple therapy' for RP-ILD.
抗 MDA5 相关皮肌炎(MDA5 相关 DM)是特发性炎性肌病的一种不常见表现,通常为无肌病性,伴进行性快速、治疗抵抗性间质性肺病和不良预后,特别是在伴有同时发生的进行性快速间质性肺病(RP-ILD)的患者中。我们报告了两例 MDA5 相关 DM 病例,其中一例患者尽管针对 RP-ILD 进行了“强化三联疗法”,但仍导致死亡。